chronic pain epidemiology forecast insight

DelveInsight’s ‘Chronic Pain - Epidemiology Forecast to 2034’ report delivers an in-depth understanding of the disease, historical and forecasted Chronic Pain epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2021-2034

Chronic Pain Understanding

Chronic Pain Overview

Chronic pain is any pain that lasts for more than three months. The pain can gradually grow worse and recur intermittently, outlasting the normal process of recovery and adversely affecting the person’s well-being. Pain is supposed to cease after damaged tissue recovers until the root cause is treated. However, for no apparent biological reason, chronic pain can continue even after injuries heal. Depending on the cause, it may last up to 6 months or even longer. However, some painful conditions may persist for years.

The most common sources of chronic pain include low back pain, headache (migraine), neuropathic pain (Neuralgia), musculoskeletal pain (Fibromyalgia), cancer pain, post-operative pain, and arthritic pain (Osteoarthritis, Rheumatoid Arthritis). Chronic pain can cause significant psychological and emotional trauma and often limits an individual’s ability to function fully. It is a common complaint in older adults. A person may have more than one chronic pain condition at a time. Someone may experience chronic pain long after they are injured or without any apparent cause. In some cases, more than one factor may be involved.

Chronic pain often leads to vegetative signs (e.g., lassitude, sleep disturbance, decreased appetite, loss of taste for food, weight loss, diminished libido, constipation), which develop gradually. Constant, unremitting pain may lead to depression and anxiety and interfere with almost all activities. Patients may become inactive, withdraw socially, and become preoccupied with physical health. Psychological and social impairment may be severe, causing a virtual lack of function.

Chronic Pain Diagnosis

Diagnosing chronic pain is not easy, as there are no tools to quantify pain. Diagnosis often involves a series of tests and procedures, as well as a review of symptoms and medical history. There is no way to measure pain objectively. Only the person with chronic pain can describe how much pain he or she is feeling. A doctor will first ask questions about the symptoms and factors that trigger pain, further investigating the location of the, how long it has been going on, and whether it is sharp or dull, constant, or occurs off and on. Sometimes a patient will be asked to rate how bad the pain is by using a numerical scale and giving more details. The doctor will do a physical exam and may order additional diagnostic tests. The diagnostic tests that are useful in the diagnosis of Chronic Pain include imaging tests like x-rays, bone scans, MRI, etc., and nerve tests like Electromyography (EMG), and some more. Other than this, physical, neurological, and mental health exams and some blood tests and urine analysis may also be used.

Epidemiology Perspective by DelveInsight

The Chronic Pain epidemiology division provides insights about historical and current Chronic Pain patient pool and forecasted trends for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

In the year 2020, the total prevalent case of Chronic Pain was 187,786,024 cases in the 7MM which are expected to grow during the study period, i.e., 2021-2034.

The disease epidemiology covered in the report provides historical as well as forecasted Chronic Pain epidemiology [segmented as Total Prevalent Cases of Chronic Pain, Total Diagnosed Cases of Chronic Pain, Age-specific Cases of Chronic Pain, Cause-specific Cases of Chronic Pain, Severity-specific Cases of Chronic Pain, and Treated cases of Chronic Pain] in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2021 to 2034.

Country Wise- Chronic Pain Epidemiology

Estimates show that the highest cases of Chronic Pain in the 7MM were in the United States, followed by Japan, the United Kingdom, Germany, France, Italy, and Spain in 2020.

• In the United States, the total number of diagnosed cases of Chronic Pain was 35,619,201 cases in the year 2020 which are expected to grow during the study period, i.e., 2021-2034.
• In the 7MM, the total age-specific cases of Chronic Pain were 5,058,587, 27,646,436, 47,930,610, 37,049,954, and 4,885,450 for the age group 18–24 years, 25–44 years, 45–64 years, 65–84 years, and ≥85 years respectively, in the year 2020.
• In the 7MM, the total cause-specific cases of Chronic Pain were 66,139,200, 33,251,314, 3,499,035, 16,211,708, 3,828,085, 11,664,901, 3,519,997, and 5,259,033 for Chronic back pain, Osteoarthritis (OA), Rheumatoid arthritis (RA), Migraine, Fibromyalgia, Neuralgia, Cancer pain, and Post-operative pain, respectively in the year 2020.
• In the 7MM, the total severity-specific cases of Chronic Pain were 38,024,980 and 84,546,057 for mild cases and moderate to severe cases, respectively in the year 2020.
• In the 7MM, the total treated cases of Chronic Pain was 93,918,570 cases in the year 2020 which are expected to grow during the study period, i.e. 2021-2034.
• In the United States, the total number of prevalent cases of Chronic Pain was 52,769,187 cases in the year 2020 which are expected to grow during the study period, i.e., 2021-2034.
• In the year 2020, the total prevalent cases of Chronic Pain were 92,698,547 cases in EU-5 which are expected to grow during the study period, i.e., 2021-2034.
• In Japan, the total number of prevalent cases of Chronic Pain was 42,318,290 cases in the year 2020 which are expected to grow during the study period, i.e., 2021-2034.

Scope of the Report

• The Chronic Pain report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns.
• The Chronic Pain Report and Model provide an overview of the risk factors and global trends of Chronic Pain in the seven major markets (7MM: The United States, Germany, France, Italy, Spain, and the United Kingdom, and Japan)
• The report provides insight about the historical and forecasted patient pool of Chronic Pain in seven major markets covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
• The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
• The report assesses the disease risk and burden and highlights the unmet needs of Chronic Pain.
• The report provides the segmentation of the Chronic Pain epidemiology by total prevalent cases in the 7MM.
• The report provides the segmentation of the Chronic Pain epidemiology by total diagnosed cases in the 7MM.
• The report provides the segmentation of the Chronic Pain epidemiology by age-specific cases in the 7MM.
• The report provides the segmentation of the Chronic Pain epidemiology by cause-specific cases in the 7MM.
• The report provides the segmentation of the Chronic Pain epidemiology by severity in the 7MM.
• The report provides the segmentation of the Chronic Pain epidemiology by treated cases in the 7MM.

Report Highlights

• 10-Year Forecast of Chronic Pain epidemiology
• 7MM Coverage
• Total Prevalent Cases of Chronic Pain
• Total Diagnosed Cases of Chronic Pain
• Age-specific Cases of Chronic Pain
• Cause-specific Cases of Chronic Pain
• Severity-specific Cases of Chronic Pain
• Treated Cases of Chronic Pain

KOL-Views

We interview KOL’s and SMEs ' opinions through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM concerning the patient population of Chronic Pain?
• What are the key findings of the Chronic Pain epidemiology across the 7MM and which country will have the highest number of patients during the study period (2021-2034)?
• What would be the total number of patients with Chronic Pain across the 7MM during the study period (2021-2034)?
• Among the EU5 countries, which country will have the highest number of patients during the study period (2021-2034)?
• At what CAGR the patient population is expected to grow in the 7MM during the study period (2021-2034)?
• What are the various recent and upcoming events which are expected to improve the diagnosis of Chronic Pain?

Reasons to buy

The Chronic Pain Epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Chronic Pain market
• Quantify patient populations in the global Chronic Pain market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the gender that presents the best opportunities for Chronic Pain therapeutics in each of the markets covered
• Understand the magnitude of the Chronic Pain population by its severity
• The Chronic Pain epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists
• The Chronic Pain Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population